查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611828

目标定序市场：按产品类型、应用和最终用户划分 - 2025-2030 年全球预测

Targeted Sequencing Market by Product Type (Consumables, Platforms, Services), Application (Cardiovascular Diseases, Hereditary Diseases, Infectious Diseases), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年标靶定序市场估值为62.3亿美元，预计2024年将达76亿美元，复合年增长率为20.30%，预计2030年将达227.3亿美元。

标靶定序是一种用于分析基因组特定区域而不是整个基因序列的技术，透过专注于与特定疾病或病症相关的兴趣区域，使其既具有时间效益又具有成本效益。这种需求源于其提供对基因突变的全面洞察并促进个人化医疗、癌症研究和罕见疾病诊断进步的能力。开发用途广泛，包括临床诊断、药物开发、农业基因组学和分子生物学研究，最终用途是医疗保健、生物技术和农业领域。该市场受到定定序方法技术进步、基因研究资金增加以及遗传疾病盛行率增加等因素的支持。随着个人化医疗和伴同性诊断需求的增加，标靶定序的采用预计将会增加。最近的机会来自于生物资讯工具的进步和定序技术成本的降低。公司可以透过投资提高效率和精度的创新技术以及将服务扩展到基因研究势头强劲的新兴市场来利用这些优势。

主要市场统计
基准年[2023] 62.3亿美元
预计年份 [2024] 76亿美元
预测年份 [2030] 227.3亿美元
复合年增长率（%） 20.30%

然而，市场成长面临初始成本高、监管核准流程复杂以及资料解释挑战等限制。进一步的障碍包括缺乏熟练的专家来分析资料以及关于基因隐私的伦理辩论。为了克服这些问题，企业应该专注于开发使用者友善的自动化平台，并鼓励与教育机构合作进行人才培养。

创新的机会在于提高定序的准确性和速度，结合人工智慧进行更好的资料分析，以及探索标靶定序在动物学、人类学等其他领域的新应用。鑑于市场的快节奏性质及其对技术进步的高度依赖，行业相关人员应强调研究伙伴关係和持续发展，以在这个充满活力的领域中保持竞争力。

市场动态：揭示快速发展的标靶定序市场的关键市场洞察

供需的动态交互作用正在改变标靶定序市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 标靶定序技术由于结果快、准确性高而在临床诊断中广泛采用
    • 农业领域更采用分析植物遗传潜力的方法
    • 精准医学标靶定序应用的增加
  • 市场限制因素
    • 缺乏计算资源和人员来分析和解释临床资料
  • 市场机会
    • 持续关注标靶测序新技术开发
    • 政府和私人公司加强对大规模测序技术的支持
  • 市场挑战
    • 关于目标序列资料保护的道德和隐私问题

波特五力：驾驭目标定序市场的策略工具

波特的五力架构是了解标靶定序市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解目标定序市场的外部影响

外部宏观环境因素在塑造目标定序市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解目标序列市场的竞争状况

对靶向测序市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵目标序列市场供应商绩效评估

FPNV定位矩阵是评估目标定序市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製目标序列市场的成功之路

靶向测序市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 标靶定序技术因其结果快、准确率高而广泛应用于临床诊断。
      • 农业中越来越多采用分析植物遗传潜力
      • 拓展标靶序列在精准医疗的应用
    • 抑制因素
      • 缺乏计算资源和人员来分析和解释临床资料
    • 机会
      • 持续关注新技术开发新型标靶定序技术
      • 政府和私营部门增加对大规模定序技术的支持
    • 任务
      • 关于目标序列资料保护的道德和隐私问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 目标定序市场：依产品类型

  • 消耗品
  • 平台
  • 服务

第七章目标序列市场：依应用分类

  • 心血管疾病
  • 遗传疾病
  • 感染疾病
  • 神经系统疾病
  • 肿瘤学
  • 生殖健康

第 8 章 目标定序市场：依最终使用者划分

  • 学术研究所
  • 临床实验室
  • 合约调查机构
  • 製药和生物技术公司

第九章美洲标靶定序市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区目标定序市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲目标定序市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 10x Genomics, Inc.
  • A-Alpha Bio, Inc.
  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • DH Life Sciences, LLC
  • Element Biosciences
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Macrogen, Inc.
  • MGI Tech Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Paragon Genomics, Inc.
  • PerkinElmer, Inc.
  • Psomagen, Inc.
  • QIAGEN NV
  • Singular Genomics Systems, Inc.
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
Product Code: MRR-1E2F1ED7E6A7

The Targeted Sequencing Market was valued at USD 6.23 billion in 2023, expected to reach USD 7.60 billion in 2024, and is projected to grow at a CAGR of 20.30%, to USD 22.73 billion by 2030.

Targeted sequencing is a technique used to analyze specific areas of the genome rather than the entire genetic sequence, making it both time-efficient and cost-effective by focusing on regions of interest that are pertinent to particular diseases or conditions. Its necessity stems from its ability to provide comprehensive insights into genetic mutations, facilitating advancements in personalized medicine, cancer research, and rare disease diagnosis. Applications extend into clinical diagnosis, drug development, agrigenomics, and molecular biology research, with end-use across healthcare, biotechnology, and agricultural sectors. The market is buoyed by factors such as technological advancements in sequencing methods, increased genetic research funding, and the growing prevalence of genetic disorders. Adoption of targeted sequencing is expected to rise as the demand for personalized medicine and companion diagnostics increases. Recent opportunities arise from advancements in bioinformatics tools and the decreasing cost of sequencing technologies. Companies can capitalize on these by investing in innovative technologies that increase efficiency and accuracy, as well as expanding their services to emerging markets where genetic research is gaining momentum.

KEY MARKET STATISTICS
Base Year [2023] USD 6.23 billion
Estimated Year [2024] USD 7.60 billion
Forecast Year [2030] USD 22.73 billion
CAGR (%) 20.30%

However, market growth faces limitations such as high initial costs, complex regulatory approval processes, and data interpretation challenges. Additionally, a lack of skilled professionals for data analysis and an ethical debate surrounding genetic privacy may pose hurdles. To overcome these, businesses should focus on developing user-friendly, automated platforms and foster collaborations with educational institutions for workforce training.

Innovation opportunities lie in enhancing sequencing accuracy and speed, integrating AI for better data analysis, and exploring new applications of targeted sequencing in other fields like zoology and anthropology. Considering the market's nature, which is fast-paced and heavily reliant on technological advances, industry stakeholders should emphasize research partnerships and continuous development to maintain a competitive edge in this dynamic sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Targeted Sequencing Market

The Targeted Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Extensive adoption of targeted sequencing technologies in clinical diagnostics due to rapid result time and higher accuracy
    • Emerging adoption in the agriculture sector to analyze the genetic potential of plants
    • Increased application of targeted sequencing for precision medicines
  • Market Restraints
    • Lack of the computational resources and staffing to analyze and interpret clinical data
  • Market Opportunities
    • Continuous focus on new technology development novel targeted sequencing technologies
    • Increased support from government and private sector for large scale sequencing technology
  • Market Challenges
    • Ethical and privacy concerns related to targeted sequencing data protection

Porter's Five Forces: A Strategic Tool for Navigating the Targeted Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Targeted Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Targeted Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Targeted Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Targeted Sequencing Market

A detailed market share analysis in the Targeted Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Targeted Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Targeted Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Targeted Sequencing Market

A strategic analysis of the Targeted Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Targeted Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., A-Alpha Bio, Inc., Agilent Technologies, Inc., Azenta Life Sciences, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., CD Genomics, DH Life Sciences, LLC, Element Biosciences, F. Hoffmann-La Roche Ltd., Illumina, Inc., LGC Limited, Macrogen, Inc., MGI Tech Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Paragon Genomics, Inc., PerkinElmer, Inc., Psomagen, Inc., QIAGEN N.V., Singular Genomics Systems, Inc., Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Targeted Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Consumables, Platforms, and Services.
  • Based on Application, market is studied across Cardiovascular Diseases, Hereditary Diseases, Infectious Diseases, Neurological Disorders, Oncology, and Reproductive Health.
  • Based on End-User, market is studied across Academic & Research Institutes, Clinical Laboratories, Contract Research Organization, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Extensive adoption of targeted sequencing technologies in clinical diagnostics due to rapid result time and higher accuracy
      • 5.1.1.2. Emerging adoption in the agriculture sector to analyze the genetic potential of plants
      • 5.1.1.3. Increased application of targeted sequencing for precision medicines
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of the computational resources and staffing to analyze and interpret clinical data
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous focus on new technology development novel targeted sequencing technologies
      • 5.1.3.2. Increased support from government and private sector for large scale sequencing technology
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and privacy concerns related to targeted sequencing data protection
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Targeted Sequencing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Platforms
  • 6.4. Services

7. Targeted Sequencing Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Diseases
  • 7.3. Hereditary Diseases
  • 7.4. Infectious Diseases
  • 7.5. Neurological Disorders
  • 7.6. Oncology
  • 7.7. Reproductive Health

8. Targeted Sequencing Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Clinical Laboratories
  • 8.4. Contract Research Organization
  • 8.5. Pharmaceutical & Biotechnology Companies

9. Americas Targeted Sequencing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Targeted Sequencing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Targeted Sequencing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. A-Alpha Bio, Inc.
  • 3. Agilent Technologies, Inc.
  • 4. Azenta Life Sciences
  • 5. BGI Genomics Co., Ltd.
  • 6. Bio-Rad Laboratories, Inc.
  • 7. CD Genomics
  • 8. DH Life Sciences, LLC
  • 9. Element Biosciences
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Illumina, Inc.
  • 12. LGC Limited
  • 13. Macrogen, Inc.
  • 14. MGI Tech Co., Ltd.
  • 15. Oxford Nanopore Technologies PLC
  • 16. Pacific Biosciences of California, Inc.
  • 17. Paragon Genomics, Inc.
  • 18. PerkinElmer, Inc.
  • 19. Psomagen, Inc.
  • 20. QIAGEN N.V.
  • 21. Singular Genomics Systems, Inc.
  • 22. Takara Bio Inc.
  • 23. Tecan Trading AG
  • 24. Thermo Fisher Scientific Inc.
  • 25. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. TARGETED SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. TARGETED SEQUENCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TARGETED SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TARGETED SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TARGETED SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TARGETED SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TARGETED SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TARGETED SEQUENCING MARKET DYNAMICS
  • TABLE 7. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HEREDITARY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. TARGETED SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. TARGETED SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023